Clinical trial

Phase II Study of ZD6474 in Advanced NSCLC

NCT00290537

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2006-01-01

PhasePHASE2

Study timeline

Study start (unknown)2006-01-01Date precision: month

Registry last updated2016-05-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Interventions

ZD6474DRUG

CarboplatinDRUG · verified · RxNorm: carboplatin

PaclitaxelDRUG · verified · RxNorm: paclitaxel

Sponsors & collaborators

M.D. Anderson Cancer Centerlead sponsor

AstraZenecacollaborator

Mapped research locations

HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00290537 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.